Detalhe da pesquisa
1.
Patterns, Predictors, and Intercenter Variability in Empiric Gram-Negative Antibiotic Use Across 928 United States Hospitals.
Clin Infect Dis
; 76(3): e1224-e1235, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35737945
2.
The risk of inappropriate empiric treatment and its outcomes based on pathogens in non-ventilated (nvHABP), ventilated (vHABP) hospital-acquired and ventilator-associated (VABP) bacterial pneumonia in the US, 2012-2019.
BMC Infect Dis
; 22(1): 775, 2022 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36199012
3.
5 versus 10 Units of Intravenous Insulin for Hyperkalemia in Patients With Moderate Renal Dysfunction.
J Emerg Med
; 62(3): 298-305, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35058093
4.
Evaluation of Peripheral Administration of 10% Calcium Chloride in a Retrospective, Single-Center Electronic Health Record Cohort.
J Emerg Nurs
; 48(4): 484-491, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35787779
5.
Epsom Salt Ingestion Leading to Severe Hypermagnesemia Necessitating Dialysis.
J Emerg Med
; 58(5): 767-770, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32389435
6.
Incidence of Adverse Events During Peripheral Administration of Sodium Chloride 3.
J Intensive Care Med
; 33(1): 48-53, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28372499
7.
Dexmedetomidine for refractory adrenergic crisis in familial dysautonomia.
Clin Auton Res
; 27(1): 7-15, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27752785
8.
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab.
J Clin Oncol
; 42(12): 1403-1414, 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215355
9.
Methods to appraise available evidence and adequacy of data from a systematic literature review to conduct a robust network meta-analysis of treatment options for patients with hospital-acquired or ventilator-associated bacterial pneumonia.
PLoS One
; 18(1): e0279844, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36598902
10.
Cost-effectiveness of imipenem/cilastatin/relebactam for hospital-acquired and ventilator-associated bacterial pneumonia.
J Comp Eff Res
; 12(3): e220113, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36688591
11.
Risk of relapse and readmission among hospitalized adults with carbapenem non-susceptible gram-negative infections.
Curr Med Res Opin
; 39(6): 881-888, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37178145
12.
Evaluation of inpatient medication guidance from an artificial intelligence chatbot.
Am J Health Syst Pharm
; 80(24): 1822-1829, 2023 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37611187
13.
Risk Factors Associated with Severe Clostridioides difficile Infection in Patients with Cancer.
Infect Dis Ther
; 12(1): 209-225, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36443547
14.
Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA.
JAC Antimicrob Resist
; 5(1): dlac131, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36601551
15.
Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms.
Infect Dis Ther
; 11(4): 1443-1457, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35334080
16.
The Comparative Effectiveness of Ceftolozane/Tazobactam versus Aminoglycoside- or Polymyxin-Based Regimens in Multi-Drug-Resistant Pseudomonas aeruginosa Infections.
Antibiotics (Basel)
; 11(5)2022 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35625270
17.
Recurrent Clostridioides difficile infection worsens anxiety-related patient-reported quality of life.
J Patient Rep Outcomes
; 6(1): 49, 2022 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35567724
18.
Antibacterial data synthesis challenges: a systematic review of treatments for complicated Gram-negative urinary tract infections.
J Comp Eff Res
; 10(18): 1385-1400, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34672210
19.
Systematic Literature Review of Real-world Evidence of Ceftolozane/Tazobactam for the Treatment of Respiratory Infections.
Infect Dis Ther
; 10(3): 1227-1252, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34278551
20.
Real-world use of ceftolozane/tazobactam: a systematic literature review.
Antimicrob Resist Infect Control
; 10(1): 68, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33832545